Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Zoledronic acid may have anti-tumour properties

Dr Robert Coleman - Professor of Medical Oncology, University of Sheffield
Zoledronic acid may have anti-tumour properties ( Dr Robert Coleman - Professor of Medical Oncology, University of Sheffield )
11 Mar 2009

Herceptin Increases event-free survival in locally advanced HER2-postive breast cancer

Dr Luca Gianni - Director of Medical Oncology, National Cancer Institute, Milan
Herceptin Increases event-free survival in locally advanced HER2-postive breast cancer ( Dr Luca Gianni - Director of Medical Oncology, National Cancer Institute, Milan )
11 Mar 2009

New genetic modelling improves screening for breast cancer

Dr Kathie Dalessandri - Physician Scientist at the University of California, San Francisco
New genetic modelling improves screening for breast cancer ( Dr Kathie Dalessandri - Physician Scientist at the University of California, San Francisco )
11 Mar 2009

New biomarker predicts anthracycline response

Dr John Bartlett - Professor of Molecular Pathology, Edinburgh University
New biomarker predicts anthracycline response ( Dr John Bartlett - Professor of Molecular Pathology, Edinburgh University )
11 Mar 2009

Continuing adjuvant tamoxifen leads to higher quality of life

Dr Shozo Ohsumi - Chief of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan
Continuing adjuvant tamoxifen leads to higher quality of life ( Dr Shozo Ohsumi - Chief of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan )
11 Mar 2009

BIG 1-98: Letrozole vs tamoxifen

Dr Alan Coates - School of Public Health, University of Sydney
BIG 1-98: Letrozole vs tamoxifen ( Dr Alan Coates - School of Public Health, University of Sydney )
11 Mar 2009

Poor prognosis on small, HER2 positive tumours

Dr Ana M. Gonzalez-Angula - Department of Breast Medical Oncology, Department of Systems Biology at the University of Texas M.D. Anderson Cancer Center
Poor prognosis on small, HER2 positive tumours ( Dr Ana M. Gonzalez-Angula - Department of Breast Medical Oncology, Department of Systems Biology at the University of Texas M.D. Anderson Cancer Center )
9 Mar 2009

Predictive value of HER2 and topoisomerase II alpha in early breast cancer patients treated with CMF or anthracycline-based adjuvant therapy

Dr Angelo Di Leo - Sandro Pitigliani Medical Oncology Unit, Prato Hospital
Predictive value of HER2 and topoisomerase II alpha in early breast cancer patients treated with CMF or anthracycline-based adjuvant therapy ( Dr Angelo Di Leo - Sandro Pitigliani Medical Oncology Unit, Prato Hospital )
9 Mar 2009

ECCO 15 - ESMO 34 Executive Scientific Programme Committee

ECCO-ESMO Roundtable discussion - Full Version
ECCO 15 - ESMO 34 Executive Scientific Programme Committee ( ECCO-ESMO Roundtable discussion - Full Version )
16 Feb 2009

10 new genes increase risk of breast cancer

Professor Douglas Easton, Cancer Research UK Genetic Epidemiology Unit, Cambridge University
10 new genes increase risk of breast cancer ( Professor Douglas Easton, Cancer Research UK Genetic Epidemiology Unit, Cambridge University )
12 Jan 2009

Various molecular imaging devices for non-invasive assessment of protein function and gene-expression pathways

Professor David R. Piwnica-Worms, Director of the Molecular Imaging Center, Washington University
Various molecular imaging devices for non-invasive assessment of protein function and gene-expression pathways ( Professor David R. Piwnica-Worms, Director of the Molecular Imaging Center, Washington University )
12 Jan 2009

Prophylactic surgery for BRCA1 and BRCA2 carriers

Dr. William Wood, Chairman of the Department of Surgery, Emory University School of Medicine
Prophylactic surgery for BRCA1 and BRCA2 carriers ( Dr. William Wood, Chairman of the Department of Surgery, Emory University School of Medicine )
12 Jan 2009

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation